FDA Rejects RP-1 in Melanoma: What the Deep Dive Will Unpack
The FDA has declined to approve RP-1 for melanoma. Medscape's data deep dive walks through what the agency's reasoning means for the melanoma drug pipeline and clinical practice.
Topic
Rp 1
Topic